Remdesivir, which is manufactured by pharma giant Gilead Sciences has been hailed as the frontrunner in the treatment of novel coronavirus, as scientists and medical researchers race against time to find a potential cure or vaccine for the same.

In a statement, the Drugs Controller General of India said, “(Remdesivir) approved on June 1 under emergency use with the condition for five dose administration,”

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here